rewirebio.iobenchmarks
Configuration

ESM1b PLLR indel score (Brandes et al. 2023)

ESM-1b in-frame indel score: the pseudo-log-likelihood of the mutated protein sequence minus that of the wild-type sequence.

4 evaluations · 4 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Evaluations and results

4 evaluations · 4 results. Different protocols are not a single leaderboard.

Protocol: ClinVar in-frame indel pathogenicity, ROC-AUC (Brandes et al. 2023 Fig. 6b, Supplementary Table 2)

Sorted by AUROC (ROC-AUC, pathogenic versus benign ClinVar all in-frame indels; zero-shot) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationProtocol and datasetAUROC (ROC-AUC, pathogenic versus benign ClinVar all in-frame indels; zero-shot)AUROC (ROC-AUC, pathogenic versus benign ClinVar deletion-insertions; zero-shot)AUROC (ROC-AUC, pathogenic versus benign ClinVar deletions; zero-shot)AUROC (ROC-AUC, pathogenic versus benign ClinVar insertions; zero-shot)
ESM1b PLLR indel score (Brandes et al. 2023)EvaluationClinVar in-frame indels, pathogenic vs benign (Brandes et al. 2023)0.869Not reportedNot reportedNot reported
ESM1b PLLR indel score (Brandes et al. 2023)EvaluationClinVar in-frame deletions (Brandes et al. 2023)Not reportedNot reported0.869Not reported
ESM1b PLLR indel score (Brandes et al. 2023)EvaluationClinVar in-frame deletion-insertions (Brandes et al. 2023)Not reported0.857Not reportedNot reported
ESM1b PLLR indel score (Brandes et al. 2023)EvaluationClinVar in-frame insertions (Brandes et al. 2023)Not reportedNot reportedNot reported0.859
All 4 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: ESM1b PLLR indel score (Brandes et al. 2023)Protocol: ClinVar in-frame indel pathogenicity, ROC-AUC (Brandes et al. 2023 Fig. 6b, Supplementary Table 2)
Dataset subset: ClinVar in-frame deletions (Brandes et al. 2023)
0.869 AUROC (ROC-AUC, pathogenic versus benign ClinVar deletions; zero-shot)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ESM1b-PLLR on deletions (Brandes et al. 2023)

gfm-guides-20261014-esm1b-protocol-clinvar-inframe-indels

Aggregation: Not reported

Brandes et al. 2023 Supplementary Table 2: full benchmark evaluations of ESM1b and all other methods · Supplementary Table 2 sheet 'Table_of_results_indels' cell D3, row 'ESM1b-PLLR', column 'AUC_del'
Configuration: ESM1b PLLR indel score (Brandes et al. 2023)Protocol: ClinVar in-frame indel pathogenicity, ROC-AUC (Brandes et al. 2023 Fig. 6b, Supplementary Table 2)
Dataset subset: ClinVar in-frame deletion-insertions (Brandes et al. 2023)
0.857 AUROC (ROC-AUC, pathogenic versus benign ClinVar deletion-insertions; zero-shot)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ESM1b-PLLR on deletion-insertions (Brandes et al. 2023)

gfm-guides-20261014-esm1b-protocol-clinvar-inframe-indels

Aggregation: Not reported

Brandes et al. 2023 Supplementary Table 2: full benchmark evaluations of ESM1b and all other methods · Supplementary Table 2 sheet 'Table_of_results_indels' cell E3, row 'ESM1b-PLLR', column 'AUC_delins'
Configuration: ESM1b PLLR indel score (Brandes et al. 2023)Protocol: ClinVar in-frame indel pathogenicity, ROC-AUC (Brandes et al. 2023 Fig. 6b, Supplementary Table 2)
Dataset: ClinVar in-frame indels, pathogenic vs benign (Brandes et al. 2023)
0.869 AUROC (ROC-AUC, pathogenic versus benign ClinVar all in-frame indels; zero-shot)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ESM1b-PLLR on all in-frame indels (Brandes et al. 2023)

gfm-guides-20261014-esm1b-protocol-clinvar-inframe-indels

Aggregation: Not reported

Brandes et al. 2023 Supplementary Table 2: full benchmark evaluations of ESM1b and all other methods · Supplementary Table 2 sheet 'Table_of_results_indels' cell B3, row 'ESM1b-PLLR', column 'AUC_indels'
Configuration: ESM1b PLLR indel score (Brandes et al. 2023)Protocol: ClinVar in-frame indel pathogenicity, ROC-AUC (Brandes et al. 2023 Fig. 6b, Supplementary Table 2)
Dataset subset: ClinVar in-frame insertions (Brandes et al. 2023)
0.859 AUROC (ROC-AUC, pathogenic versus benign ClinVar insertions; zero-shot)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ESM1b-PLLR on insertions (Brandes et al. 2023)

gfm-guides-20261014-esm1b-protocol-clinvar-inframe-indels

Aggregation: Not reported

Brandes et al. 2023 Supplementary Table 2: full benchmark evaluations of ESM1b and all other methods · Supplementary Table 2 sheet 'Table_of_results_indels' cell C3, row 'ESM1b-PLLR', column 'AUC_ins'

Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.

Use this configuration

How it works, versions and access
Strengths, limitations and unresolved questions

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: gfm-guides-20261014-esm1b-config-esm1b-pllr

areas
protein-function
contexts
clinical_research
method types
foundation_model
reported name
ESM1b-PLLR
version
esm1b_t33_650M_UR50S
parameters
esm1b_t33_650M_UR50S; sequences longer than 1,022 amino acids scored on a 1,022-residue window around the variant; PLL(mut) - PLL(WT) ('vanilla' PLLR)
foundation model eligible
true
source locator
Methods 'Generalized effect scores for indels and stop-gain variants' paragraphs 1-3; Supplementary Table 2 sheet 'Table_of_results_indels' row 'ESM1b-PLLR'
Related records

Suggest a correction